This is a prospective, non-blinded study of hypogonadal men with a history of testosterone
therapy who became azoospermic or severely oligospermic and wish to avoid symptoms of
hypogonadism during their recovery of spermatogenesis in an effort to establish paternity.
The study will determine if Natesto can alleviate hypogonadal symptoms while preserving the
recovery of spermatogenesis